Clinical Trial Update: Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for first-line metastatic non-small cell lung cancer evaluating datopotamab deruxtecan with pembrolizumab, with or without platinu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Datopotamab Deruxtecan (datopotamab deruxtecan)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Metastatic Non Small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING